Article
Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.
Pharmacogenetics - 1 Nov 2004
Shi Jing-Yi, Shi Zhan-Zhong, Zhang Su-Jiang, Zhu Yong-Mei, Gu Bai-Wei, Li Guo, Bai Xue-Tao, Gao Xiao-Dong, Hu Jiong, Jin Wei, Huang Wei, Chen Zhu, Chen Sai-Juan
Abstract excerpt
Development of resistance to 1-beta-arabinofuranosylcytosine (AraC) is a major obstacle in the treatment of patients with acute myeloid leukaemia (AML). Deficiency of functional deoxycytidine kinase (dCK) plays an important role in AraC resistance in vitro. We screened 5378 bp sequences of the dCK gene, including all exons and the 5' flanking region, and identified two single nucleotide polymorphisms (SNPs) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
